Pharmacokinetics and Metabolism of Methotrexate: An Example for the Use of Clinical Pharmacology in Pediatric Oncology
- 1 January 1990
- journal article
- review article
- Published by Taylor & Francis in Pediatric Hematology and Oncology
- Vol. 7 (1) , 13-33
- https://doi.org/10.3109/08880019009034317
Abstract
(1990). Pharmacokinetics and Metabolism of Methotrexate: An Example for the Use of Clinical Pharmacology in Pediatric Oncology. Pediatric Hematology and Oncology: Vol. 7, No. 1, pp. 13-33. doi: 10.3109/08880019009034317Keywords
This publication has 55 references indexed in Scilit:
- Methotrexate bioavailability after oral and intramuscular administration in childrenThe Journal of Pediatrics, 1987
- Pharmacokinetics of Anticancer Drugs in ChildrenClinical Pharmacokinetics, 1987
- Pharmacokinetics of oral and intramuscular methotrexate in children with acute lymphoblastic leukaemiaCancer Chemotherapy and Pharmacology, 1987
- Long-term neuropsychologic sequelae of childhood leukemia: Correlation with CT brain scan abnormalitiesThe Journal of Pediatrics, 1985
- Protein binding of methotrexate in sera from normal human beings: effect of drug concentration, pH, temperature, and storageJournal of Pharmacological Methods, 1981
- The protein binding of methotrexate by the serum of normal subjectsEuropean Journal of Clinical Pharmacology, 1979
- HIGH DOSE METHOTREXATE IN ACUTE LYMPHOCYTIC LEUKEMIA IN CHILDHOODActa Paediatrica, 1978
- Pharmacokinetics of high-dose methotrexate treatment in childrenEuropean Journal of Clinical Pharmacology, 1978
- Use of Plasma Pharmacokinetics to Predict and Prevent Methotrexate ToxicityNew England Journal of Medicine, 1977
- Treatment of leukemia with large doses of methotrexate and folinic acid: clinical-biochemical correlatesJournal of Clinical Investigation, 1969